Table 1 Prevalence of adverse events
| Â | Phacoemulsification | Extracapsular | Total | P-value | |||
|---|---|---|---|---|---|---|---|
|  | (n = 415)* | (n = 60)†| (n = 475) ‡ | (Fisher's exact test) | |||
| Â | n | (%age) | n | (%age) | n | (%age) | Â |
2 hour follow-up | Â | Â | Â | Â | Â | Â | Â |
Corneal clarity | 32 | 8.1% | 6 | 10.9% | 38 | 8.5% | P = 0.45 |
Incision stability | 2 | 0.5% | 0 | 0.0% | 2 | 0.5% | P = 1.00 |
Anterior chamber reaction | 25 | 6.4% | 12 | 22.2% | 37 | 8.3% | P = 0.001 |
IOP ≥ 30 mmHg | 27 | 7.2% | 3 | 6.0% | 30 | 7.1% | P = 1.00 |
IOP ≥ 35 mmHg | 15 | 4.0% | 0 | 0.0% | 15 | 3.5% | P = 0.24 |
Next day follow-up | Â | Â | Â | Â | Â | Â | Â |
Corneal clarity | 21 | 5.3% | 5 | 9.1% | 26 | 5.8% | P = 0.35 |
Incision stability | 0 | 0.0% | 2 | 3.6% | 2 | 0.5% | P = 0.02 |
Anterior chamber reaction | 28 | 7.1% | 15 | 27.8% | 43 | 9.6% | P < 0.001 |
IOP ≥ 30 mmHg | 33 | 8.8% | 4 | 8.0% | 37 | 8.7% | P = 1.00 |
IOP ≥ 35 mmHg | 15 | 4.0% | 3 | 6.0% | 18 | 4.3% | P = 0.46 |
New problems first appearing the next day | Â | Â | Â | Â | Â | Â | Â |
Corneal clarity | 7 | 1.8% | 2 | 3.6% | 9 | 2.0% | P = 0.31 |
Incision stability | 0 | 0.0% | 2 | 3.6% | 2 | 0.5% | P = 0.02 |
Anterior chamber reaction | 9 | 2.3% | 4 | 7.4% | 13 | 2.9% | P = 0.06 |
IOP ≥ 30 mmHg | 26 | 7.0% | 3 | 6.0% | 29 | 6.9% | P = 1.00 |
IOP ≥ 35 mmHg | 13 | 3.5% | 3 | 6.0% | 16 | 3.8% | P = 0.42 |